يعرض 1 - 20 نتائج من 340 نتيجة بحث عن '"Kuruvilla J."', وقت الاستعلام: 0.58s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المصدر: Journal of Clinical Oncology, 2024

    وصف الملف: application/pdf

  4. 4
    Academic Journal
  5. 5
    Academic Journal

    المساهمون: Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)

    المصدر: ISSN: 0006-4971.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    Relation: info:eu-repo/semantics/altIdentifier/pmid/38557775; hal-04603620; https://hal.univ-lille.fr/hal-04603620; https://hal.univ-lille.fr/hal-04603620/document; https://hal.univ-lille.fr/hal-04603620/file/blood.2023021620.pdf; PUBMED: 38557775

  6. 6
    Academic Journal

    المساهمون: Kuruvilla J., Armand P., Hamadani M., Kline J., Moskowitz C.H., Avigan D., Brody J.D., Ribrag V., Herrera A.F., Morschhauser F., Kanate A., Zinzani P.L., Bitran J., Ghesquieres H., Schuster S.J., Farooqui M., Marinello P., Bartlett N.L.

    مصطلحات موضوعية: B-cell lymphoma, Non-Hodgkin lymphoma, PD-L1, pembrolizumab

    وصف الملف: ELETTRONICO

    Relation: info:eu-repo/semantics/altIdentifier/pmid/36398795; info:eu-repo/semantics/altIdentifier/wos/WOS:000889500100001; volume:64; issue:1; firstpage:130; lastpage:139; numberofpages:10; journal:LEUKEMIA & LYMPHOMA; https://hdl.handle.net/11585/960713; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85142278083

  7. 7
    Academic Journal

    المساهمون: Ansell S.M., Brockelmann P.J., von Keudell G., Lee H.J., Santoro A., Zinzani P.L., Collins G.P., Cohen J.B., de Boer J.P., Kuruvilla J., Savage K.J., Trneny M., Provencio M., Jager U., Willenbacher W., Wen R., Akyol A., Mikita-Geoffroy J., Shipp M.A., Engert A., Armand P.

    وصف الملف: ELETTRONICO

    Relation: info:eu-repo/semantics/altIdentifier/pmid/37530622; info:eu-repo/semantics/altIdentifier/wos/WOS:001097076600001; volume:7; issue:20; firstpage:6266; lastpage:6274; numberofpages:9; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/960011; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85175416545; https://ashpublications.org/bloodadvances/article/7/20/6266/497222/Nivolumab-for-relapsed-refractory-classical

  8. 8
    Academic Journal

    المساهمون: Zinzani P.L., Santoro A., Gritti G., Brice P., Barr P.M., Kuruvilla J., Cunningham D., Kline J., Johnson N.A., Mehta-Shah N., Lisano J., Wen R., Akyol A., Moskowitz A.J.

    وصف الملف: ELETTRONICO

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:001080509800001; volume:7; issue:18; firstpage:5272; lastpage:5280; numberofpages:9; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/960064; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85173482930; https://ashpublications.org/bloodadvances/article/7/18/5272/496496/Nivolumab-combined-with-brentuximab-vedotin-for-R

  9. 9
    Academic Journal

    المساهمون: Université de Lille, CHU Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365

    مصطلحات موضوعية: Non-Hodgkin lymphoma, pembrolizumab, B-cell lymphoma, PD-L1

    وصف الملف: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

    Relation: Leukemia & lymphoma; Leuk Lymphoma; http://hdl.handle.net/20.500.12210/82385

  10. 10
    Academic Journal

    المساهمون: Zinzani P.L., Ramchandren R., Santoro A., Paszkiewicz-Kozik E., Gasiorowski R., Johnson N.A., de Oliveira J.S.R., Buccheri V., Perini G.F., Dickinson M., McDonald A., Ozcan M., Sekiguchi N., Zhu Y., Raut M., Saretsky T.L., Nahar A., Kuruvilla J.

    وصف الملف: STAMPA

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34644372; info:eu-repo/semantics/altIdentifier/wos/WOS:000754639300004; volume:6; issue:2; firstpage:590; lastpage:599; numberofpages:10; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/904791; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123548552; https://ashpublications.org/bloodadvances/article/6/2/590/477276/Quality-of-life-analysis-of-pembrolizumab-vs

  11. 11
    Academic Journal

    Relation: pii: 477276; Zinzani, P. L., Ramchandren, R., Santoro, A., Paszkiewicz-Kozik, E., Gasiorowski, R., Johnson, N. A., de Oliveira, J. S. R., Buccheri, V., Perini, G. F., Dickinson, M., McDonald, A., Ozcan, M., Sekiguchi, N., Zhu, Y., Raut, M., Saretsky, T. L., Nahar, A. & Kuruvilla, J. (2022). Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma. BLOOD ADVANCES, 6 (2), pp.590-599. https://doi.org/10.1182/bloodadvances.2021004970.; http://hdl.handle.net/11343/301626

  12. 12
    Academic Journal

    Relation: pii: 486254; Salles, G., Schuster, S. J., Dreyling, M., Fischer, L., Kuruvilla, J., Patten, P. E. M., von Tresckow, B., Smith, S. M., Jimenez-Ubieto, A., Davis, K. L., Anjos, C., Chu, J., Zhang, J., Bodoni, C. L., Thieblemont, C., Fowler, N. H., Dickinson, M., Martinez-Lopez, J., Wang, Y. & Link, B. K. (2022). Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma. BLOOD ADVANCES, 6 (22), pp.5835-5843. https://doi.org/10.1182/bloodadvances.2022008150.; http://hdl.handle.net/11343/335833

  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
  17. 17
  18. 18
    Academic Journal

    المساهمون: Shah J., Shacham S., Kauffman M., Daniele P., Tomaras D., Tremblay G., Casasnovas R.-O., Maerevoet M., Zijlstra J., Follows G., P Vermaat J.S., Kalakonda N., Goy A.H., Choquet S., Den Neste E.V., Hill B.T., Thieblemont C., Cavallo F., La Cruz F.D., Kuruvilla J., Hamad N., Bouabdallah R., Jager U., Caimi P., Gurion R., Warzocha K., Bakhshi S., Sancho J.M., Schuster M., Egyed M., Offner F., Vasilakopoulos T.P., Samal P., Nagy A., Ku M., Canales Albendea M.A.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/33528286; info:eu-repo/semantics/altIdentifier/wos/WOS:000613867400001; volume:17; issue:11; firstpage:1295; lastpage:1310; numberofpages:16; journal:FUTURE ONCOLOGY; http://hdl.handle.net/2318/1790897; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103094087

  19. 19
    Conference
  20. 20
    Report